Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

KyungMann Kim

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Biometrics|December 1, 2022
Nonparametric scanning tests of homogeneity for hierarchical models with continuous covariatesDavid Todem, Wei-Wen Hsu, KyungMann Kim
Statistica Neerlandica|January 25, 2011
Semiparametric regression models and sensitivity analysis of longitudinal data with nonrandom dropoutsDavid Todem, Kyungmann Kim, Jason Fine, et al.
Clinical Trials (London, England)|September 6, 2014
"Right to Try" lawsColin B Begg, KyungMann Kim, James D Neaton
Statistics in Medicine|November 13, 2023
Statistical inference for time-to-event data in non-randomized cohorts with selective attritionTuo Wang, Lu Mao, Aldo Cocco, et al.
Biometrics|September 17, 2002
Group sequential methods for an ordinal logistic random-effects model under misspecificationBart Spiessens, Emmanuel Lesaffre, Geert Verbeke, et al.
The Canadian Journal of Statistics = Revue Canadienne De Statistique|June 12, 2012
Semiparametric transformation models for multivariate panel count data with dependent observation processNi Li, Do-Hwan Park, Jianguo Sun, et al.
Statistics in Medicine|February 3, 2004
Admissible two-stage designs for phase II cancer clinical trialsSin-Ho Jung, Taiyeong Lee, KyungMann Kim, et al.
Cancer Research|March 29, 2007
Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in miceNaghma Khan, Farrukh Afaq, Mee-Hyang Kweon, et al.
BMC Medical Research Methodology|May 7, 2021
Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpointsJordi Cortés Martínez, Ronald B Geskus, KyungMann Kim, et al.
Anticancer Research|October 23, 2009
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancerJason R Gee, Corrie B Burmeister, Thomas C Havighurst, et al.
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Biometrics|December 1, 2022
Nonparametric scanning tests of homogeneity for hierarchical models with continuous covariatesDavid Todem, Wei-Wen Hsu, KyungMann Kim
Statistica Neerlandica|January 25, 2011
Semiparametric regression models and sensitivity analysis of longitudinal data with nonrandom dropoutsDavid Todem, Kyungmann Kim, Jason Fine, et al.
Clinical Trials (London, England)|September 6, 2014
"Right to Try" lawsColin B Begg, KyungMann Kim, James D Neaton
Statistics in Medicine|November 13, 2023
Statistical inference for time-to-event data in non-randomized cohorts with selective attritionTuo Wang, Lu Mao, Aldo Cocco, et al.
Biometrics|September 17, 2002
Group sequential methods for an ordinal logistic random-effects model under misspecificationBart Spiessens, Emmanuel Lesaffre, Geert Verbeke, et al.
The Canadian Journal of Statistics = Revue Canadienne De Statistique|June 12, 2012
Semiparametric transformation models for multivariate panel count data with dependent observation processNi Li, Do-Hwan Park, Jianguo Sun, et al.
Statistics in Medicine|February 3, 2004
Admissible two-stage designs for phase II cancer clinical trialsSin-Ho Jung, Taiyeong Lee, KyungMann Kim, et al.
Cancer Research|March 29, 2007
Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in miceNaghma Khan, Farrukh Afaq, Mee-Hyang Kweon, et al.
BMC Medical Research Methodology|May 7, 2021
Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpointsJordi Cortés Martínez, Ronald B Geskus, KyungMann Kim, et al.
Anticancer Research|October 23, 2009
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancerJason R Gee, Corrie B Burmeister, Thomas C Havighurst, et al.
Pageof 16